Reproductive and developmental safety of nirmatrelvir (PF-07321332), an oral SARS-CoV-2 Mpro inhibitor in animal models

Isobe, Y.; Catlin, N. R.; Bowman, C. J.; Campion, S. N.; Cheung, J. R.; Nowland, W. S.; Sathish, J. G.; Stethem, C. M.; Updyke, L. W.; Cappon, G. D.

Isobe, Y.; Catlin, N. R.; Bowman, C. J.; Campion, S. N.; Cheung, J. R.; Nowland, W. S.; Sathish, J. G.; Stethem, C. M.; Updyke, L. W.; Cappon, G. D..

Congenital Anomalies ; 62(6):A12-A13, 2022.

Article in English | EMBASE | ID: covidwho-2192458

Keywords

adult; animal care; animal experiment; animal model; conference abstract; controlled study; developmental toxicity; drug safety; embryo development; ethics; female; female fertility; fertility; genotoxicity; Leporidae; male; male fertili

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: EMBASE Language: English Journal: Congenital Anomalies Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google